SE
61
-4
AA
61
5
LMT
32
2
WFC
80
-2
FMC
34
-2
ED
53
-2
NWS
60
2
HCP
62
2
MAC
65
-3
AKAM
53
2
WU
32
-2
XEL
69
-3
HPE
42
2
BF.B
37
2
ECL
62
2
ADSK
61
2
APA
30
3
AZO
53
-5
CMCSA
50
2
UNP
56
-3
SE
61
-4
AA
61
5
LMT
32
2
WFC
80
-2
FMC
34
-2
ED
53
-2
NWS
60
2
HCP
62
2
MAC
65
-3
AKAM
53
2
WU
32
-2
XEL
69
-3
HPE
42
2
BF.B
37
2
ECL
62
2
ADSK
61
2
APA
30
3
AZO
53
-5
CMCSA
50
2
UNP
56
-3
Financhill
Back

Revance Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
12

RVNC
Revance Therapeutics

Last Price:
3.64
Seasonality Move:
4.87%

7 Day Trial

ALL ACCESS PASS

$ 7

Revance Therapeutics Price Quote

$3.64
+0.03 (+-3.7%)
(Updated: November 30, 2024 at 5:55 AM ET)

Revance Therapeutics Key Stats

Sell
12
Revance Therapeutics (RVNC) is a Sell
Day range:
$3.61 - $3.84
52-week range:
$2.30 - $9.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.36
P/B ratio:
0%
Volume:
1.9M
Avg. volume:
2.4M
1-year change:
-47.98%
Market cap:
$378.7M
Revenue:
$234M
EPS:
$-1.94

How Much Does Revance Therapeutics Make?

Is Revance Therapeutics Growing As A Company?

  • What Is Revance Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.11%
  • What Is Revance Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Revance Therapeutics Stock Price Performance

What Is Revance Therapeutics 52-Week High & Low?

Revance Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Revance Therapeutics?

Is Revance Therapeutics Cash Flow Positive?

  • What Is RVNC Cash Flow From Operations?
    Cash flow from operations (TTM) is -$190.9M
  • What Is Revance Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $81.7M
  • What Is Revance Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$12.9M

Revance Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    RVNC return on invested capital is -61.49%
  • What Is Revance Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -37.25%
  • What Is RVNC Return On Equity?
    ROE is a measure of profitability and is 0%

Revance Therapeutics Earnings Date & Stock Price

Revance Therapeutics Competitors

Revance Therapeutics Dividend Yield

Revance Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 6.33%
Revenue: 10.66% -12.17%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 8
Sell Recommendations: 0
Price Target: 9.23
Upside from Last Price: 155.56%

Major Shareholders

  • How many RVNC shares are owned by institutional investors?
    122.7M RVNC shares are owned by institutional investors
  • How many RVNC shares are owned by insiders?
    2.7M RVNC shares are owned by insiders